(3r)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone and Hypothermia, Accidental

(3r)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone has been researched along with Hypothermia, Accidental in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cano, C; Girón, R; Goya, P; Martín, MI; Paez, JA; Sánchez, E	1
Bajaj, S; Barak, LS; Bowman, AL; Caron, MG; Deschamps, JR; Makriyannis, A; Paronis, C; Parrish, D; Peng, Y; Thakur, GA	1

Other Studies

2 other study(ies) available for (3r)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone and Hypothermia, Accidental

Article	Year
Discovery of 1,1-dioxo-1,2,6-thiadiazine-5-carboxamide derivatives as cannabinoid-like molecules with agonist and antagonist activity. Bioorganic & medicinal chemistry, 2007, Dec-01, Volume: 15, Issue:23 Topics: Animals; Benzoxazines; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Cannabinoids; Catalepsy; Dose-Response Relationship, Drug; Drug Design; Drug Evaluation, Preclinical; Hypothermia; Injections, Intraperitoneal; Locomotion; Male; Mice; Mice, Inbred ICR; Molecular Structure; Morpholines; Naphthalenes; Pain Measurement; Piperidines; Pyrazoles; Receptors, Cannabinoid; Rimonabant; Stereoisomerism; Thiadiazines; Vas Deferens	2007
Novel adamantyl cannabinoids as CB1 receptor probes. Journal of medicinal chemistry, 2013, May-23, Volume: 56, Issue:10 Topics: Adamantane; Analgesics; Animals; Arrestin; Body Temperature; Cannabinoid Receptor Agonists; Cannabinoids; Crystallography, X-Ray; Cyclic AMP; Dose-Response Relationship, Drug; Female; Hypothermia; Models, Molecular; Pain Measurement; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Structure-Activity Relationship	2013

Article

Year

Discovery of 1,1-dioxo-1,2,6-thiadiazine-5-carboxamide derivatives as cannabinoid-like molecules with agonist and antagonist activity.

Bioorganic & medicinal chemistry, 2007, Dec-01, Volume: 15, Issue:23

Topics: Animals; Benzoxazines; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Cannabinoids; Catalepsy; Dose-Response Relationship, Drug; Drug Design; Drug Evaluation, Preclinical; Hypothermia; Injections, Intraperitoneal; Locomotion; Male; Mice; Mice, Inbred ICR; Molecular Structure; Morpholines; Naphthalenes; Pain Measurement; Piperidines; Pyrazoles; Receptors, Cannabinoid; Rimonabant; Stereoisomerism; Thiadiazines; Vas Deferens

2007

Novel adamantyl cannabinoids as CB1 receptor probes.

Journal of medicinal chemistry, 2013, May-23, Volume: 56, Issue:10

Topics: Adamantane; Analgesics; Animals; Arrestin; Body Temperature; Cannabinoid Receptor Agonists; Cannabinoids; Crystallography, X-Ray; Cyclic AMP; Dose-Response Relationship, Drug; Female; Hypothermia; Models, Molecular; Pain Measurement; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Structure-Activity Relationship

2013